Catalyst Pharmaceuticals Inc (CPRX)
22.56
+0.63
(+2.87%)
USD |
NASDAQ |
Nov 27, 11:41
Catalyst Pharmaceuticals Shares Outstanding: 119.27M for Nov. 4, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
November 04, 2024 | 119.27M |
September 30, 2024 | 119.27M |
August 05, 2024 | 118.69M |
June 30, 2024 | 118.52M |
May 06, 2024 | 118.12M |
March 31, 2024 | 118.03M |
March 28, 2024 | 118.01M |
February 26, 2024 | 117.86M |
February 09, 2024 | 119.06M |
January 09, 2024 | 117.56M |
January 03, 2024 | 107.56M |
December 31, 2023 | 107.12M |
November 06, 2023 | 106.61M |
September 30, 2023 | 106.60M |
September 08, 2023 | 106.59M |
August 07, 2023 | 106.58M |
July 05, 2023 | 106.51M |
June 30, 2023 | 106.50M |
May 08, 2023 | 106.08M |
April 17, 2023 | 105.98M |
March 31, 2023 | 105.94M |
March 13, 2023 | 105.65M |
December 31, 2022 | 105.26M |
November 07, 2022 | 104.07M |
September 30, 2022 | 104.06M |
Date | Value |
---|---|
August 05, 2022 | 102.82M |
August 01, 2022 | 102.82M |
June 30, 2022 | 102.71M |
May 06, 2022 | 102.78M |
April 27, 2022 | 102.78M |
March 31, 2022 | 102.96M |
March 14, 2022 | 102.74M |
December 31, 2021 | 102.99M |
November 05, 2021 | 103.12M |
October 20, 2021 | 103.17M |
September 30, 2021 | 103.15M |
August 05, 2021 | 102.98M |
June 30, 2021 | 103.16M |
May 07, 2021 | 103.36M |
May 06, 2021 | 103.36M |
April 28, 2021 | 103.44M |
March 31, 2021 | 103.80M |
March 11, 2021 | 103.82M |
December 31, 2020 | 103.78M |
November 05, 2020 | 103.65M |
September 30, 2020 | 103.65M |
August 06, 2020 | 103.46M |
July 31, 2020 | 103.43M |
July 23, 2020 | 103.43M |
June 30, 2020 | 103.42M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
102.71M
Minimum
Jun 30 2022
119.27M
Maximum
Nov 04 2024
106.73M
Average
103.71M
Median
Shares Outstanding Benchmarks
Corcept Therapeutics Inc | 104.78M |
Vertex Pharmaceuticals Inc | 257.53M |
Sarepta Therapeutics Inc | 95.52M |
ADMA Biologics Inc | 236.39M |
BioVie Inc | 17.77M |